Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hybridoma Technology01:31

Hybridoma Technology

Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation, polyethylene glycol...
Cross-reactivity00:42

Cross-reactivity

Overview
Diversity of Antigen Receptors01:28

Diversity of Antigen Receptors

Antigen receptors are essential components of the immune system crucial in defending the body against foreign invaders. These receptors are present on the surface of B and T cells, enabling them to recognize antigens and mount an appropriate immune response.
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
Affinity and Avidity01:41

Affinity and Avidity

Overview
Antibody Actions01:26

Antibody Actions

Antibodies, or immunoglobulins, are critical players in the immune system's arsenal against invading pathogens. Produced by B cells and plasma cells, their primary role is to detect and bind to specific antigens, molecules found on the surface of pathogens like bacteria or viruses. Beyond antigen recognition, antibodies perform several vital functions that contribute to immune defense.
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
Special Features of Adaptive Immunity01:20

Special Features of Adaptive Immunity

The adaptive immune system, a crucial component of the overall immune response, offers a highly specialized defense against pathogens. It involves specific cell types and features, enabling it to combat infections effectively and efficiently.
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Anti-angiogenic therapies in cancer: from endogenous inhibitors to bispecific VEGF x PD-(L)1 antibodies.

Frontiers in immunology·2026
Same author

Generation and functional evaluation of STAb-T cells.

Methods in cell biology·2026
Same author

Oxidative stress-driven transcriptomic remodeling in human astrocytes reveals network signatures associated with neurodegenerative and cardiovascular processes.

Computational and structural biotechnology journal·2026
Same author

mRNA-engineered T lymphocytes secreting bispecific T cell engagers with therapeutic potential in solid tumors.

Frontiers in immunology·2025
Same author

Bispecific antibodies and nanotechnology: a strategic alliance in cancer immunotherapy.

Molecular cancer·2025
Same author

Correction: Deletion of C3G in hepatocytes impairs full liver maturation and alters glucose homeostasis.

Cell death & disease·2025
Same journal

Smart biomaterials: From responsiveness to closed-loop sensing and feedback.

Trends in biotechnology·2026
Same journal

Bacterial spores as a modular platform for the production of amyloids for materials.

Trends in biotechnology·2026
Same journal

The oriGen case and Mexico's regulatory blind spots in genomic biobanking.

Trends in biotechnology·2026
Same journal

A caspase-3-activated protein expression system for apoptosis visualization and apoptosis-pyroptosis conversion to boost antitumor activity.

Trends in biotechnology·2026
Same journal

Over 4 months of ethylene production using solid-state photosynthetic cell factories.

Trends in biotechnology·2026
Same journal

Closing the nitrogen loop in groundwater with biohybrid technologies.

Trends in biotechnology·2026
See all related articles

Related Experiment Video

Updated: Jun 13, 2026

Generation of Murine Monoclonal Antibodies by Hybridoma Technology
09:42

Generation of Murine Monoclonal Antibodies by Hybridoma Technology

Published on: January 2, 2017

Multivalent antibodies: when design surpasses evolution.

Angel M Cuesta1, Noelia Sainz-Pastor, Jaume Bonet

  • 1Hospital Universitario Puerta de Hierro, 28222 Majadahonda, Madrid, Spain.

Trends in Biotechnology
|May 8, 2010
PubMed
Summary
This summary is machine-generated.

Engineered multivalent antibodies show promise for improved solid tumor targeting in cancer diagnostics and therapy. Novel trivalent antibody formats enhance tumor targeting through improved biodistribution and functional affinity.

More Related Videos

Generation of Discriminative Human Monoclonal Antibodies from Rare Antigen-specific B Cells Circulating in Blood
13:14

Generation of Discriminative Human Monoclonal Antibodies from Rare Antigen-specific B Cells Circulating in Blood

Published on: February 6, 2018

Generation of Escape Variants of Neutralizing Influenza Virus Monoclonal Antibodies
07:55

Generation of Escape Variants of Neutralizing Influenza Virus Monoclonal Antibodies

Published on: August 29, 2017

Related Experiment Videos

Last Updated: Jun 13, 2026

Generation of Murine Monoclonal Antibodies by Hybridoma Technology
09:42

Generation of Murine Monoclonal Antibodies by Hybridoma Technology

Published on: January 2, 2017

Generation of Discriminative Human Monoclonal Antibodies from Rare Antigen-specific B Cells Circulating in Blood
13:14

Generation of Discriminative Human Monoclonal Antibodies from Rare Antigen-specific B Cells Circulating in Blood

Published on: February 6, 2018

Generation of Escape Variants of Neutralizing Influenza Virus Monoclonal Antibodies
07:55

Generation of Escape Variants of Neutralizing Influenza Virus Monoclonal Antibodies

Published on: August 29, 2017

Area of Science:

  • Immunology
  • Biotechnology
  • Oncology

Background:

  • Antibodies are crucial immune molecules selected by evolution to combat pathogens.
  • Monoclonal antibody technology enables broad applications in research, diagnostics, and cancer treatment.
  • Solid tumors present challenges for antibody-based therapies compared to hematologic malignancies.

Purpose of the Study:

  • To review advances in engineering multivalent antibodies for improved tumor targeting.
  • To discuss the potential of novel antibody formats in cancer diagnostics and therapy.

Main Methods:

  • Review of recent scientific literature on antibody engineering.
  • Analysis of novel multivalent antibody formats, including trivalent antibodies.
  • Discussion of enhanced biodistribution and functional affinity in antibody design.

Main Results:

  • Multivalent antibody formats, particularly trivalent antibodies, are being developed to overcome limitations in solid tumor targeting.
  • These engineered antibodies aim to enhance tumor targeting efficacy through optimized biodistribution and functional affinity.
  • Recent advances focus on creating novel antibody structures beyond traditional bivalent formats.

Conclusions:

  • Engineered multivalent antibodies, especially trivalent formats, offer a promising strategy to improve the efficacy of antibody-based diagnostics and therapies for solid tumors.
  • Further development in antibody engineering can enhance in vivo diagnostic and therapeutic applications.
  • Novel antibody formats represent a significant advancement in the fight against solid tumor cancers.